Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis

Psychiatry Research - Neuroimaging

Volumn 234, Issue 3, 2015, Pages 352-361

  Debernard, Laëtitia ^a,b   Melzer, Tracy R ^a,b   Alla, Sridhar ^a,b   Eagle, Jane ^a,c   Van Stockum, Saskia ^a   Graham, Charlotte ^a   Osborne, Jonathan R ^a   Dalrymple Alford, John C ^a,d   Miller, David H ^a,b,e   Mason, Deborah F ^a,b,c  

^a NEW ZEALAND BRAIN RESEARCH INSTITUTE   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d UNIVERSITY OF CANTERBURY   (New Zealand)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Atrophy; Deep grey matter; Diffusion; MRI; Perfusion; Relapsing remitting

Indexed keywords

BETA INTERFERON; GLATIRAMER;

ADULT; ARTICLE; ATTENTION; BECK DEPRESSION INVENTORY; BENTON JUDGMENT OF LINE ORIENTATION; BRAIN SIZE; CALIFORNIA VERBAL LEARNING TEST; CAUDATE NUCLEUS; COGNITION; CONTROLLED STUDY; DEEP GREY MATTER; DEPTH PERCEPTION; DIFFUSION; DIFFUSION TENSOR IMAGING; DISEASE DURATION; EXECUTIVE FUNCTION; EXPANDED DISABILITY STATUS SCALE; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; HIPPOCAMPUS; HUMAN; INFORMATION PROCESSING; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROPSYCHOLOGY; PACED AUDITORY SERIAL ADDITION TEST; PERFUSION; PRIORITY JOURNAL; PUTAMEN; STROOP TEST; THALAMUS; VISUAL MEMORY; VOLUMETRY; WORKING MEMORY; ATROPHY; BRAIN; CASE CONTROL STUDY; COGNITIVE DEFECT; COMPLICATION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES;

ADULT; ATROPHY; BRAIN; CASE-CONTROL STUDIES; CAUDATE NUCLEUS; COGNITION; COGNITION DISORDERS; FEMALE; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PUTAMEN; THALAMUS;

EID: 84958840363     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2015.10.004     Document Type: Article

References (54)

1. Akbar N., Lobaugh N.J., O'Connor P., Moradzadeh L., Scott C.J., Feinstein A. Diffusion tensor imaging abnormalities in cognitively impaired multiple sclerosis patients. Can. J. Neurol. Sci. 2010, 37(5):608-614.
2. Assaf B.A., Mohamed F.B., Abou-Khaled K.J., Williams J.M., Yazeji M.S., Haselgrove J., Faro S.H. Diffusion tensor imaging of the hippocampal formation in temporal lobe epilepsy. Am. J. Neuroradiol. 2003, 24(9):1857-1862.
3. Ashburner J., Friston K.J. Unified segmentation. Neuroimage 2005, 26(3):839-851.
4. Batista S., Zivadinov R., Hoogs M., Bergsland N., Heininen-Brown M., Dwyer M.G., Weinstock-Guttman B., Benedict R.H. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J. Neurol. 2012, 259:139-146.
5. Benedict R. Brief Visuospatial Memory Test-Revised Professional Manual 1997, Psychological Assessment Ressources, Inc., Odessa, FL.
6. Benedict R.H., Hulst H.E., Bergsland N., Schoonheim M.M., Dwyer M.G., Weinstock-Guttman B., Geurts J.J., Zivadinov R. Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients. Mult. Scler. J. 2013, 19:1478-1484.
7. Benton A.L., Hamsher K., Varney N.R., Spreen O. Contributions to Neuropsychological Assessment: A Clinical Manual 1983, Oxford, New York.
8. Bester M., Jensen J.H., Babb J.S., Tabesh A., Miles L., Herbert J., Grossman R.I., Inglese M. Non-Gaussian diffusion MRI of grey matter is associated with cognitive impairment in multiple sclerosis. Mult. Scler. J. 2015, 21(7):935-944.
9. Brass S., Benedict R.H., Weinstock-Guttman B., Munschauer F., Bakshi R. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult. Scler. J. 2006, 12(4):437-444.
10. Calabrese M., Rinaldi F., Grossi P., Mattisi I., Bernardi V., Favaretto A., Perini P., Gallo P. Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis. Mult. Scler. J. 2010, 16(10):1220-1228.
11. Calabrese M., Favaretto A., Martini V., Gallo.P. Grey matter lesions in MS: from histology to clinical implications. Prion 2013, 7(1):20-27.
12. Cappellani R., Bergsland N., Weinstock-Guttman B., Kennedy C., Carl E., Ramasamy D.P., Hagemeier J., Dwyer M.G., Patti F., Zivadinov R. Subcortical deep grey matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study. Am. J. Neuroradiol. 2014, 35:912-919.
13. Ceccarelli A., Rocca M.A., Falini A., Tortorella P., Pagani E., Rodegher M., Comi G., Scotti G., Filippi M. Normal-appearing white and grey matter damage in MS: a volumetric and diffusion tensor MRI study at 3T. J. Neurol. 2007, 254:513-518.
14. Chard D.T., Griffin C.M., Parker G.J., Kapoor R., Thompson A.J., Miller D.H. Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002, 125(2):327-337.
15. Chard D.T., Jackson J.S., Miller D.H., Wheeler-Kingshott C.A. Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J. Magn. Reson. Imaging 2010, 32(1):223-228.
16. Ciccarelli O., Werring D., Wheeler-Kingshott C., Barker G.J., Parker G.J., Thompson A.J., Miller D.H. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001, 56(7):926-933.
17. Dineen R.A., Vilisaar J., Hlinka J., Bradshaw C.M., Morgan P.S., Constantinescu C.S., Auer D.P. Disconnections as a mechanism for cognitive dysfunction in multiple sclerosis. Brain 2009, 132:239-249.
18. Debernard L., Melzer T.R., Van Stockum S., Graham C., Wheeler-Kingshott.C.A., Dalrymple-Alford J.C., Miller D.H., Mason D.F. Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis. J. Neurol., Neurosurg. Psychiatry 2014, 85(5):544-551.
19. De Jong L., Van Der Hiele K., Veer I.M., Houwing J.J., Westendorp R.G., Bollen E.L., de Bruin P.W., Middelkoop H.A., van Buchem M.A., van der Grond J. Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study. Brain 2008, 131(12):3277-3285.
20. Delis D.C., Kramer J.H., Kaplan E., Ober B. The California Verbal Learning Test-Second Edition 2000, Psychological Corporation, New York.
21. Delis D.C., Kaplan E., Kramer J. Delis-Kaplan Executive Functioning System: Examiner's Manual 2001, Psychological Corporation, San Antonio, TX.
22. Filippi M., Bozzali M., Comi G. Magnetization transfer and diffusion tensor MR imaging of basal ganglia from patients with multiple sclerosis. J. Neurol. Sci. 2001, 183(1):69-72.
23. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., Van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33(3):341-355.
24. Francis P.L., Jakubovic R., O'Connor P., Zhang L., Eilaghi A., Lee L., Carroll T.J., Mouannes-Srour J., Feinstein A., Aviv R.I. Robust perfusion deficits in cognitively impaired patients with secondary-progressive multiple sclerosis. Am. J. Neuroradiol. 2013, 34:62-67.
25. Griffin C.M., Chard D.T., Ciccarelli O., Kapoor B., Barker G.J., Thompson A.I., Miller D.H. Diffusion tensor imaging in early relapsing-remitting multiple sclerosis. Mult. Scler. J. 2001, 7:290-297.
26. Haider L., Simeonidou C., Steinberger G., Hametner S., Grigoriadis N., Deretzi G., Kovacs G.G., Kutzelnigg A., Lassmann H., Frischer J.M. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J. Neurol. Neurosurg. Psychiatry 2014, 85(12):1386-1395.
27. Hannoun S., Durand-Dubief F., Confavreux C., Ibarrola D., Streichenberger N., Cotton F., Guttmann C.R., Sappey-Marinier D. Diffusion tensor - MRI evidence for extra-axonal neuronal degeneration in caudate and thalamic nuclei of patients with multiple sclerosis. Am. J. Neuroradiol. 2012, 33(7):1363-1368.
28. Houtchens M.K., Benedict R.H.B., Kiliany R., Sharma J., Jaisani Z., Singh B., Weinstock-Guttman C.R.G., Guttmann C.R.G., Bakshi R. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007, 69(12):1213-1223.
29. Inglese M., Park S.J., Johnson G., Babb J.S., Miles L., Jaggi H., Herbert J., Grossman R.I. Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch. Neurol. 2007, 64(2):196-202.
30. Inglese M., Adhya S., Johnson G., Babb J.S., Miles L., Jaggi H., Herbert J., Grossman R.I. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J. Cereb. Blood Flow Metab. 2008, 28(1):164-171.
31. Jak A.J., Bondi M.W., Delano-Wood L., Wierenga C., Corey-Bloom J., Salmon D.P., Delis D.C. Quantification of five neuropsychological approaches to defining mild cognitive impairment. Am. J. Geriatr. Psychiatry 2009, 17(5):368-375.
32. Litvan I., Goldman J.G., Tröster A.I., Schmand B.A., Weintraub D., Petersen R.C., Mollenhauer B., Adler C.H., Marder K., Williams-Gray C.H., Aarsland D., Kulisevsky J., Rodriguez-Oroz M.C., Burn D.J., Barker R.A., Emre M. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines. Mov. Disord. 2012, 24:489-495.
33. Loewenstein D.A., Acevedo A., Small B.J., Agron J., Crocco E., Duara R. Stability of different subtypes of mild cognitive impairment among the elderly over a 2- to 3- year follow-up period. Dement. Geriatr. Cogn. Disord. 2009, 27:418-423.
34. Minagar A., Barnett M.H., Benedict R.H., Pelletier D., Pirko I., Sahraian M.A., Frohman E., Zivadinov R. The thalamus and multiple sclerosis: modern view on pathologic, imaging and clinical aspects. Neurology 2013, 80:210-219.
35. Mesaros S., Rocca M.A., Kacar K., Kostic J., Copetti M., Stosic-Opincal T., Preziosa T., Sala S., Riccitelli G., Horsfield M.A., Drulovic J., Comi G., Filippi M. Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis. Neurology 2012, 77:969-975.
36. Meyers J.E., Meyers K.R. Rey Complex Figure Test and Recognition Trial: Professional Manual 1995, Psychological Assessment Resources, Lutz, FL.
37. Muhlau M., Buck D., Forschler A., Boucard C.C., Arsic M., Schmidt P., Gaser C., Berthele A., Hoshi M., Jochim A., Kronsbein H., Zimmer C., Hemmer B., Ilg R. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI. Mult. Scler. 2013, 19(11):1485-1492.
38. Muhlert N., Sethi V., Cipolotti L., Haroon H., Parker G.J.M., Yousry T., Wheeler-Kingshott C., Miller D., Ron M., Chard D. The grey matter correlates of impaired decision-making in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2015, 86:530-536.
39. Patenaude B., Smith S.M., Kennedy D.N., Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011, 56(3):907-922.
40. Popescu V., Klaver R., Voorn P., Galis-de-Graaf Y., Knol D.L., Twisk J.W.R., Versteeg A., Schenk.G.J., Van der Valk P., Barkhof F., De Vries H.E., Vrenken H., Geurts J.J.G. What drives MRI-measured cortical atrophy in multiple sclerosis?. Mult. Scler. J. 2015, 21(10):1280-1290.
41. Rashid W., Parkes L., Ingle G., Chard D.T., Toosy A.T., Altmann D.R., Symms M.R., Tofts P.S., Thompson A.J., Miller D.H. Abnormalities of cerebral perfusion in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2004, 75(9):1288-1293.
42. Saalmann Y.B. Front. Syst. Neurosci. 2014, 8-83. 10.3389/fnsys.2014.00083.
43. Sbardella E., Tona.F., Petsas N., Pantano P. DTI measurements in multiple sclerosis: evaluation of brain damage and clinical implications. Mult. Scler. Int. 2013, 2013:671730. Epub 2013 Mar 31. 10.1155/2013/671730.
44. Schinka J.A., Loewenstein D.A., Raj A., Schoenberg M.R., Banko J.L., Potter H., Duara R. Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates. Am. J. Geriatr. Psychiatry 2010, 18(8):684-691.
45. Schoonheim M.M., Popescu V., Rueda Lopes F.C., Wiebenga O.T., Vrenken H., Douw L., Polman C.H., Geurts J.J., Barkhof F. Subcortical atrophy and cognition: sex effects in multiple sclerosis. Neurology 2012, 79(17):1754-1761.
46. Schoonheim M.M., Hulst H.E., Brandt R.B., Strik M., Wink A.M., Uitdehaag B.M.J., Barkhof F., Geurts J.J.G. Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology 2015, 84(8):776-783.
47. Simon J.H., Bermel R.A., Rudick R.A. Simple MRI metrics to contribute to optimal care of the patients with multiple sclerosis. Am. J. Neuroradiol. 2014, 35:831-832.
48. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E., Niazy R.K., Saunders J., Vickers J., Zhang Y., De Stefano N., Brady J.M., Matthews P.M. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004, 23:S208-S219.
49. Strauss E., Sherman E.M.S., Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary 2006, Oxford University Press, New York. 3rd ed.
50. Tovar-Moll F., Evangelous I.E., Chiu A.W., Richert N.D., Ostuni J.L., Ohayon J.M., Auh S., Ehrmantraut M., Talagala S.L., McFarland H.F., Bagnato F. Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T. Am. J. Neuroradiol. 2009, 30:1380-1386.
51. Trapp B.D., Stys P.K. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 2009, 8(3):280-291.
52. Tziortzi A.C., Haber S.N., Searle G.E., Tsoumpas C., Long C.J., Shotbolt P., Douaud G., Jbabdi S., Behrens T.E., Rabiner E.A., Jenkinson M., Gunn R.N. Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomography. Cereb. Cortex 2014, 24(5):1165-1177.
53. Varga A.W., Johnson G., Babb J.S., Herbert J., Grossman R.I., Inglese M. White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J. Neurol. Sci. 2009, 282(1):28-33.
54. Zhang Y., Zabad R., Wei X., Metz L., Mitchell J. Deep grey matter black T2* on 3 T magnetic resonance imaging correlates with disability in multiple sclerosis. Mult. Scler. J. 2007, 213(7):880-883.